IMMUNOBIO R&D kandi ikabyara ibikoresho byiza byo gupima COVID-19, kandi ikanatanga impapuro zidakata na Proteine.
Hangzhou Immuno Biotech Co., Ltd nishirahamwe ryambere muri Immuno Group. Itsinda rya Hangzhou Immuno Biotech ryateguye urukurikirane rwa poroteyine hamwe n’ibikoresho byipimisha byihuse mu nganda zipima vitro hakiri kare. Buhoro buhoro, IMMUNO yari azwi nkumufatanyabikorwa mwiza wa R&D kandi utanga ibicuruzwa byamatungo byihuse.
reba byinshiHamwe na patenti zirenga 50, zigenda zihindurwa buhoro buhoro mubicuruzwa na serivisi kubakiriya
Ibicuruzwa birenga 15% byumwaka bishora mubushakashatsi nibicuruzwa
Mu mwaka ushize, twatanze inkunga ya tekiniki na serivisi ku masosiyete arenga 100 mu nganda imwe
Mu myaka yashize, umuvuduko wubwiyongere bwikigo buri mwaka urenga 50%, abakiriya benshi kandi benshi baraduhitamo
Reka ubutumwa bwawe